Recently, HGF has been shown to be present in the tumor microenvironment and plays a critical role in the maintenance of the stemness properties of CSCs, suggesting that molecules that inhibit the HGF pathway may be potential anti-CSC reagents [4,5]. The gene discussed is HGF; the disease is neoplasm.